Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07604519

Multi-Ingredient Supplementation in Professional Football Players

Conditions: Sports Performance, Cognitive Performance During Physical Activity, Fatigue, Recovery, Football Players

Sex: Male
Ages: 18 Years – 35 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 100
Sponsor: Vizja University in Warsaw

Location: Professional Football Training Center Budapest

Summary

This randomized double-blind placebo-controlled trial will investigate the effects of multi-ingredient supplementation containing taurine, caffeine, and phosphatidylserine on physical performance, cognitive function, cognitive fatigue responses, recovery, sleep quality, and autonomic nervous system activity in elite male soccer players. Participants will complete a 14-day supplementation protocol and undergo football-specific performance, reaction-time, cognitive-fatigue, recovery, and sleep-related assessments before and after the intervention. The study aims to determine whether phosphatidylserine dose influences physical, cognitive, fatigue-related, and recovery-related outcomes when combined with taurine and caffeine.

Eligibility Criteria

Inclusion Criteria: \- Inclusion Criteria: * Professional male football players aged 18-35 years * Regular participation in team training and competitive matches * Clinically healthy status confirmed prior to participation * Written informed consent provided Exclusion Criteria: * Current musculoskeletal injury or illness * Chronic metabolic, cardiovascular, or neurological disease * Regular medication use * Current use of dietary supplements or ergogenic aids * Smoking or excessive alcohol consumption * Known hypersensitivity to any study supplement ingredient Exclusion Criteria: \-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07604519). StuddyBuddy aggregates publicly available trial information.